šŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia flag Malaysia Ā· Delayed Price Ā· Currency is MYR
1.030
-0.050 (-4.63%)
At close: Nov 20, 2026

Duopharma Biotech Berhad Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Duopharma Biotech Berhad stock has a consensus rating of "Strong Buy" and an average price target of RMĀ 1.67. The average 1-year stock price forecast is 61.75% higher than the current stock price, while the lowest is RMĀ 1.47 (+42.72%) and the highest is RMĀ 1.79 (+73.79%).

Price Target: RMĀ 1.67 (+61.75%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
PriceRMĀ 1.47RMĀ 1.67RMĀ 1.72RMĀ 1.79
Change+42.72%+61.75%+66.99%+73.79%

Analyst Ratings

The average analyst rating for Duopharma Biotech Berhad stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy555555
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total555555

Financial Forecast

Revenue This Year
974.68M
from 931.69M
Increased by 4.61%
Revenue Next Year
1.01B
from 974.68M
Increased by 3.50%
EPS This Year
0.11
from 0.09
Increased by 23.43%
EPS Next Year
0.11
from 0.11
Increased by 1.60%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
639.18M696.72M704.73M813.70M931.69M974.68M
Revenue Growth
12.16%9.00%1.15%15.46%14.50%4.61%
Gross Profit
253.98M279.82M268.33M301.54M363.14M419.11M
Gross Margin
39.74%40.16%38.08%37.06%38.98%43.00%
Operating Income
88.77M92.91M78.71M100.26M133.78M158.83M
Net Income
65.68M70.11M52.65M62.65M87.46M109.06M
EPS
----0.090.11
EPS Growth
----39.63%23.43%
Forward PE
20.9715.9114.7714.7412.089.18
Dividend / Share
0.020.020.020.030.050.05
Dividend Growth
-55.43%5.75%-30.44%51.67%20.04%
Free Cash Flow
----80.08M146.75M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.

Revenue Forecast

Revenue202620272028
High1.2B
Avg974.7M
Low897.2M

Revenue Growth

Revenue Growth202620272028
High
23.7%
Avg
4.6%
Low
-3.7%

EPS Forecast

EPS202620272028
High0.12
Avg0.11
Low0.11

EPS Growth

EPS Growth202620272028
High
26.5%
Avg
23.4%
Low
21.0%